Inhibition of cell growth by BrMC through inactivation of Akt in HER2/neuoverexpressing breast cancer cells

By        

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1632-1638

Spandidos Publications

Access to resources Recommend Favorite

Bisphosphonate Induced Growth Inhibition of Breast Cancer Cells is Augmented by p38 Inhibition

By Merrell M.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 3, 2003-10 ,pp. : 231-241

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells

By Yang Qu   Zhang Shanyong   Kang Mingyang   Dong Rongpeng   Zhao Jianwu  

Oncology Reports, Vol. 33, Iss. 5, 2015-05 ,pp. : 2537-2544

Spandidos Publications

Access to resources Recommend Favorite

Targeted Inhibition of AKT in Pancreatic Cancer

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-01 ,pp. : 288-295

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: Implication of EGFR tyrosine kinase inhibitors

By                            

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 685-692

Spandidos Publications

Access to resources Recommend Favorite